Structural and Computational Studies of HIV-1 RNA

Overview

Journal RNA Biol

Specialty Molecular Biology

Date 2023 Dec 15

PMID 38100535

Authors

Lev Levintov

Harish Vashisth

Affiliations

Soon will be listed here.

Abstract

Viruses remain a global threat to animals, plants, and humans. The type 1 human immunodeficiency virus (HIV-1) is a member of the retrovirus family and carries an RNA genome, which is reverse transcribed into viral DNA and further integrated into the host-cell DNA for viral replication and proliferation. The RNA structures from the HIV-1 genome provide valuable insights into the mechanisms underlying the viral replication cycle. Moreover, these structures serve as models for designing novel therapeutic approaches. Here, we review structural data on RNA from the HIV-1 genome as well as computational studies based on these structural data. The review is organized according to the type of structured RNA element which contributes to different steps in the viral replication cycle. This is followed by an overview of the HIV-1 transactivation response element (TAR) RNA as a model system for understanding dynamics and interactions in the viral RNA systems. The review concludes with a description of computational studies, highlighting the impact of biomolecular simulations in elucidating the mechanistic details of various steps in the HIV-1's replication cycle.

Citing Articles

Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New Thiazolidinone Derivatives as NNRTIs and SARS-CoV-2 Main Protease Inhibitors.

Fesatidou M, Petrou A, Geronikaki A Chem Biodivers. 2024; 21(12):e202401697.

PMID: 39442074 PMC: 11644116. DOI: 10.1002/cbdv.202401697.

Bioinformatics Insights on Viral Gene Expression Transactivation: From HIV-1 to SARS-CoV-2.

Patarca R, Haseltine W Int J Mol Sci. 2024; 25(6).

PMID: 38542351 PMC: 10970485. DOI: 10.3390/ijms25063378.

References

Goodsell D, Jewett A, Olson A, Forli S . Integrative modeling of the HIV-1 ribonucleoprotein complex. PLoS Comput Biol. 2019; 15(6):e1007150. PMC: 6592547. DOI: 10.1371/journal.pcbi.1007150. View

Zhang B, Qiu H, Jiang J, Liu J, Shi Y . 3D structure stability of the HIV-1 TAR RNA in ion solutions: A coarse-grained model study. J Chem Phys. 2019; 151(16):165101. DOI: 10.1063/1.5126128. View

Paillart J, Dettenhofer M, Yu X, Ehresmann C, Ehresmann B, Marquet R . First snapshots of the HIV-1 RNA structure in infected cells and in virions. J Biol Chem. 2004; 279(46):48397-403. DOI: 10.1074/jbc.M408294200. View

Tazi J, Bakkour N, Marchand V, Ayadi L, Aboufirassi A, Branlant C . Alternative splicing: regulation of HIV-1 multiplication as a target for therapeutic action. FEBS J. 2010; 277(4):867-76. DOI: 10.1111/j.1742-4658.2009.07522.x. View

Kumar A, Vashisth H . Conformational dynamics and energetics of viral RNA recognition by lab-evolved proteins. Phys Chem Chem Phys. 2021; 23(43):24773-24779. PMC: 8579469. DOI: 10.1039/d1cp03822b. View

Tsai K, Vasudevan A, Martinez Campos C, Emery A, Swanstrom R, Cullen B . Acetylation of Cytidine Residues Boosts HIV-1 Gene Expression by Increasing Viral RNA Stability. Cell Host Microbe. 2020; 28(2):306-312.e6. PMC: 7429276. DOI: 10.1016/j.chom.2020.05.011. View

Du Z, Lind K, James T . Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening. Chem Biol. 2002; 9(6):707-12. DOI: 10.1016/s1074-5521(02)00151-5. View

Levintov L, Vashisth H . Ligand Recognition in Viral RNA Necessitates Rare Conformational Transitions. J Phys Chem Lett. 2020; 11(14):5426-5432. DOI: 10.1021/acs.jpclett.0c01390. View

Das K, Martinez S, Bandwar R, Arnold E . Structures of HIV-1 RT-RNA/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA/DNA: insights into requirements for RNase H cleavage. Nucleic Acids Res. 2014; 42(12):8125-37. PMC: 4081091. DOI: 10.1093/nar/gku487. View

10.

Engelman A, Cherepanov P . The structural biology of HIV-1: mechanistic and therapeutic insights. Nat Rev Microbiol. 2012; 10(4):279-90. PMC: 3588166. DOI: 10.1038/nrmicro2747. View

11.

Charpentier B, Stutz F, Rosbash M . A dynamic in vivo view of the HIV-I Rev-RRE interaction. J Mol Biol. 1997; 266(5):950-62. DOI: 10.1006/jmbi.1996.0858. View

12.

Schulze-Gahmen U, Echeverria I, Stjepanovic G, Bai Y, Lu H, Schneidman-Duhovny D . Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex. Elife. 2016; 5. PMC: 5072841. DOI: 10.7554/eLife.15910. View

13.

Patwardhan N, Cai Z, Umuhire Juru A, Hargrove A . Driving factors in amiloride recognition of HIV RNA targets. Org Biomol Chem. 2019; 17(42):9313-9320. PMC: 6909927. DOI: 10.1039/c9ob01702j. View

14.

Belashov I, Crawford D, Cavender C, Dai P, Beardslee P, Mathews D . Structure of HIV TAR in complex with a Lab-Evolved RRM provides insight into duplex RNA recognition and synthesis of a constrained peptide that impairs transcription. Nucleic Acids Res. 2018; 46(13):6401-6415. PMC: 6061845. DOI: 10.1093/nar/gky529. View

15.

Kim J, Choi H, Seong B . The folding competence of HIV-1 Tat mediated by interaction with TAR RNA. RNA Biol. 2017; 14(7):926-937. PMC: 5546542. DOI: 10.1080/15476286.2017.1311455. View

16.

Kieft J . Viral IRES RNA structures and ribosome interactions. Trends Biochem Sci. 2008; 33(6):274-83. PMC: 2706518. DOI: 10.1016/j.tibs.2008.04.007. View

17.

Sakuragi S, Yokoyama M, Shioda T, Sato H, Sakuragi J . SL1 revisited: functional analysis of the structure and conformation of HIV-1 genome RNA. Retrovirology. 2016; 13(1):79. PMC: 5106843. DOI: 10.1186/s12977-016-0310-9. View

18.

Huang W, Emani P, Varani G, Drobny G . Ultraslow Domain Motions in HIV-1 TAR RNA Revealed by Solid-State Deuterium NMR. J Phys Chem B. 2016; 121(1):110-117. PMC: 6785184. DOI: 10.1021/acs.jpcb.6b11041. View

19.

Lawrence D, Stover C, Noznitsky J, Wu Z, Summers M . Structure of the intact stem and bulge of HIV-1 Psi-RNA stem-loop SL1. J Mol Biol. 2003; 326(2):529-42. DOI: 10.1016/s0022-2836(02)01305-0. View

20.

Ennifar E, Paillart J, Bodlenner A, Walter P, Weibel J, Aubertin A . Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell. Nucleic Acids Res. 2006; 34(8):2328-39. PMC: 1458285. DOI: 10.1093/nar/gkl317. View